Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
1.090
+0.020 (1.87%)
At close: Jun 26, 2026, 4:00 PM EDT
1.050
-0.040 (-3.67%)
After-hours: Jun 26, 2026, 7:46 PM EDT
SNTI Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for SNTI stock have an average target of 12, which predicts an increase of 1,000.92% from the current stock price of 1.09.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 15, 2026.
Analyst Ratings
The average analyst rating for SNTI stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Oct '25 | Nov '25 | Dec '25 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 3 | 3 | 3 | 3 |
| Buy | 1 | 2 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $12 | Buy | Maintains | $12 | +1,000.92% | May 15, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $12 | Buy | Reiterates | $12 | +1,000.92% | May 15, 2026 |
Financial Forecast
Revenue This Year
33.33K
from 22.00K
Increased by 51.50%
Revenue Next Year
50.00K
from 33.33K
Increased by 50.02%
EPS This Year
-1.16
from -2.73
EPS Next Year
-0.95
from -1.16
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 100,000 | 100,000 | |
| Avg | 33,330 | 50,000 | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 354.5% | 200.0% | |
| Avg | 51.5% | 50.0% | |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -1.16 | -0.95 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.